Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents

  • Technology appraisal guidance
  • TA13
  • Published: 

This guidance has been replaced by NICE technology appraisal guidance 98 [Replaced by NICE guideline NG87].